Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ADP-ribosylation is a posttranslational protein modification catalyzed by two classes of enzymes: mono-ADP-ribosyltransferase and poly-ADP-ribose polymerases. We previously demonstrated that long-term alcohol intake remarkably enhanced an endogenous ADP-ribosylation of a 58 kDa protein in rat liver and also identified the 58 kDa protein as
phosphoglucomutase
(
PGM
). To assess biological significance of this phenomenon, we tested the effects of long-term alcohol intake on
PGM
activities in connection with posttranslational modification of the protein. ADP-ribosylation of
PGM
was mono- rather than poly-ADP-ribosylation. Also, nonenzymatic binding of ADP-ribose was excluded. It was of note that ADP-ribosylation of exogenous
PGM
was remarkably increased by adding rat liver plasma membranes, and that the extent of the increase was greater in alcohol-fed rats than in pair-fed controls. Furthermore,
PGM
activities were significantly increased after long-term alcohol intake concomitant with increased
ADP-ribosyltransferase
activities toward
PGM
. In view of the variety of roles of
PGM
in the liver, such as carbohydrate metabolism and Ca2+ homeostasis, it is tempting to speculate that increased ADP-ribosylation of
PGM
may play a role in long-term alcohol effects on hepatocytes.
...
PMID:Long-term alcohol effects on hepatic phosphoglucomutase activities in relation to posttranslational modification of the protein. 962 87